The two organizations join forces to develop pioneering AI-based solutions for efficient chemical synthesis planning that accelerates the development of new drugs.
CAS, a division...
Horizon Therapeutics plc announced positive and statistically significant topline results from its randomized, double-masked, placebo-controlled Phase 4 clinical trial evaluating TEPEZZA for the treatment of...
AUTOCRYPT, an industry-leading provider of automotive cybersecurity and connected mobility solutions, announced that it has been officially accredited by the AICPA/CICA WebTrust Program for...
CAS, a division of the American Chemical Society, recently completed a major project with The National Institute of Industrial Property (INPI) of Brazil to...
